Market Capitalization (Millions $) |
191 |
Shares
Outstanding (Millions) |
57 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-126 |
Cash Flow (TTM) (Millions $) |
127 |
Capital Exp. (TTM) (Millions $) |
12 |
Graphite Bio Inc
Graphite Bio Inc is a biotechnology company focused on developing genetic medicines to treat rare diseases. Their approach involves using gene editing technology and next-generation AAV gene therapy platforms to develop precise and efficient treatments. Graphite Bio aims to address the limitations of traditional gene therapies by utilizing advanced technologies to optimize therapeutic outcomes. Their goal is to bring transformative treatments to patients with rare diseases that currently have limited or no treatment options.
Company Address: 611 Gateway Blvd South San Francisco 94080 CA
Company Phone Number: 484-0886 Stock Exchange / Ticker: NASDAQ GRPH
|